Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Theca Cells | 5 | 2012 | 17 | 1.590 |
Why?
|
| Chorionic Gonadotropin | 3 | 2012 | 86 | 1.040 |
Why?
|
| Cellulose | 2 | 2024 | 19 | 0.980 |
Why?
|
| Biomass | 1 | 2024 | 17 | 0.930 |
Why?
|
| Plant Leaves | 1 | 2024 | 42 | 0.920 |
Why?
|
| Small Molecule Libraries | 6 | 2024 | 118 | 0.910 |
Why?
|
| DNA | 8 | 2024 | 1594 | 0.720 |
Why?
|
| Mammary Glands, Animal | 2 | 2019 | 483 | 0.630 |
Why?
|
| Cell Cycle Proteins | 2 | 2012 | 645 | 0.570 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2018 | 244 | 0.540 |
Why?
|
| Tamoxifen | 1 | 2018 | 363 | 0.530 |
Why?
|
| Estrogen Receptor alpha | 1 | 2019 | 454 | 0.510 |
Why?
|
| Insulin | 2 | 2012 | 1208 | 0.510 |
Why?
|
| Multiprotein Complexes | 2 | 2012 | 207 | 0.470 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2018 | 617 | 0.470 |
Why?
|
| Signal Transduction | 4 | 2023 | 4500 | 0.450 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 716 | 0.440 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2012 | 425 | 0.430 |
Why?
|
| Androgens | 2 | 2012 | 276 | 0.410 |
Why?
|
| Polyesters | 2 | 2024 | 40 | 0.410 |
Why?
|
| Luteinizing Hormone | 1 | 2012 | 132 | 0.400 |
Why?
|
| Transcriptome | 1 | 2018 | 902 | 0.390 |
Why?
|
| beta-Lactamase Inhibitors | 2 | 2023 | 55 | 0.370 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 1872 | 0.350 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2024 | 523 | 0.340 |
Why?
|
| Cyclic AMP | 1 | 2010 | 248 | 0.330 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2009 | 27 | 0.320 |
Why?
|
| beta-Lactamases | 4 | 2024 | 192 | 0.320 |
Why?
|
| Escherichia coli | 3 | 2024 | 983 | 0.320 |
Why?
|
| Proteins | 2 | 2019 | 1040 | 0.300 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 2 | 2024 | 31 | 0.290 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2010 | 488 | 0.290 |
Why?
|
| Tensile Strength | 2 | 2024 | 38 | 0.280 |
Why?
|
| Sirolimus | 3 | 2012 | 220 | 0.260 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 2478 | 0.260 |
Why?
|
| Phosphoproteins | 3 | 2012 | 399 | 0.250 |
Why?
|
| Rats | 5 | 2012 | 3665 | 0.250 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2012 | 1218 | 0.250 |
Why?
|
| Cells, Cultured | 4 | 2018 | 3046 | 0.230 |
Why?
|
| Sansevieria | 1 | 2024 | 1 | 0.230 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2024 | 153 | 0.230 |
Why?
|
| Contraceptive Agents, Male | 1 | 2024 | 26 | 0.220 |
Why?
|
| Phosphorylation | 3 | 2012 | 1611 | 0.220 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2012 | 555 | 0.220 |
Why?
|
| Contraception | 1 | 2024 | 58 | 0.220 |
Why?
|
| Biofilms | 1 | 2024 | 91 | 0.220 |
Why?
|
| Animals | 11 | 2024 | 33842 | 0.210 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2023 | 47 | 0.210 |
Why?
|
| Copper | 1 | 2023 | 61 | 0.210 |
Why?
|
| Ribosomal Protein S6 | 2 | 2012 | 13 | 0.190 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2012 | 20 | 0.190 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 2 | 2012 | 162 | 0.190 |
Why?
|
| Anti-Bacterial Agents | 2 | 2023 | 2398 | 0.190 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 2 | 2012 | 7 | 0.180 |
Why?
|
| Androstenedione | 2 | 2012 | 11 | 0.180 |
Why?
|
| Corchorus | 1 | 2020 | 2 | 0.180 |
Why?
|
| Composite Resins | 1 | 2020 | 5 | 0.180 |
Why?
|
| Egg Shell | 1 | 2020 | 4 | 0.180 |
Why?
|
| Glass | 1 | 2020 | 12 | 0.180 |
Why?
|
| Gene Silencing | 2 | 2012 | 236 | 0.180 |
Why?
|
| Cell Proliferation | 3 | 2012 | 2310 | 0.170 |
Why?
|
| Nanostructures | 1 | 2020 | 52 | 0.170 |
Why?
|
| Transcription Factors | 1 | 2010 | 2586 | 0.170 |
Why?
|
| Hydrocarbons, Halogenated | 1 | 2019 | 5 | 0.170 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2012 | 340 | 0.170 |
Why?
|
| RNA, Small Interfering | 2 | 2012 | 667 | 0.160 |
Why?
|
| Nitro Compounds | 1 | 2019 | 18 | 0.160 |
Why?
|
| Ovarian Neoplasms | 1 | 2023 | 409 | 0.160 |
Why?
|
| Amines | 1 | 2019 | 36 | 0.160 |
Why?
|
| Boron Compounds | 1 | 2019 | 33 | 0.160 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2019 | 239 | 0.160 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2018 | 17 | 0.150 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 510 | 0.140 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2018 | 202 | 0.140 |
Why?
|
| Female | 10 | 2024 | 65619 | 0.140 |
Why?
|
| Mice, Nude | 1 | 2018 | 696 | 0.130 |
Why?
|
| Binding Sites | 1 | 2019 | 1294 | 0.130 |
Why?
|
| Peptides | 1 | 2020 | 790 | 0.130 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 254 | 0.130 |
Why?
|
| Carrier Proteins | 2 | 2012 | 1021 | 0.130 |
Why?
|
| Ribosomal Protein S6 Kinases | 2 | 2012 | 51 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 998 | 0.130 |
Why?
|
| Catalysis | 3 | 2020 | 125 | 0.120 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 883 | 0.120 |
Why?
|
| Bacterial Proteins | 1 | 2020 | 878 | 0.120 |
Why?
|
| Receptors, Estrogen | 1 | 2018 | 791 | 0.120 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 861 | 0.110 |
Why?
|
| Catalytic Domain | 2 | 2024 | 158 | 0.100 |
Why?
|
| Cholesterol Side-Chain Cleavage Enzyme | 1 | 2012 | 4 | 0.100 |
Why?
|
| Colforsin | 1 | 2012 | 48 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2012 | 83 | 0.100 |
Why?
|
| Enzyme Activation | 2 | 2012 | 619 | 0.100 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2012 | 52 | 0.100 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1680 | 0.100 |
Why?
|
| Enzyme Induction | 1 | 2012 | 103 | 0.100 |
Why?
|
| Mice | 4 | 2024 | 17547 | 0.100 |
Why?
|
| Genome-Wide Association Study | 1 | 2019 | 1637 | 0.100 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2012 | 110 | 0.100 |
Why?
|
| Cattle | 1 | 2012 | 562 | 0.090 |
Why?
|
| Genomics | 1 | 2019 | 1474 | 0.090 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2012 | 165 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 352 | 0.090 |
Why?
|
| Gene Expression Regulation | 2 | 2010 | 2525 | 0.090 |
Why?
|
| Cyclin D3 | 1 | 2010 | 10 | 0.090 |
Why?
|
| Gene Library | 2 | 2023 | 220 | 0.090 |
Why?
|
| RNA Interference | 1 | 2012 | 496 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 355 | 0.090 |
Why?
|
| Metformin | 1 | 2012 | 147 | 0.090 |
Why?
|
| Cyclin D1 | 1 | 2010 | 112 | 0.090 |
Why?
|
| Aminoglutethimide | 1 | 2009 | 2 | 0.080 |
Why?
|
| Hydroxycholesterols | 1 | 2009 | 2 | 0.080 |
Why?
|
| Ovary | 1 | 2012 | 389 | 0.080 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2009 | 27 | 0.080 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 72 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2009 | 113 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 467 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2009 | 1012 | 0.070 |
Why?
|
| Cholesterol | 1 | 2009 | 528 | 0.070 |
Why?
|
| Blood-Testis Barrier | 1 | 2024 | 11 | 0.060 |
Why?
|
| Receptors, Eph Family | 1 | 2024 | 21 | 0.060 |
Why?
|
| Flowers | 1 | 2024 | 7 | 0.060 |
Why?
|
| Receptor, EphA2 | 1 | 2024 | 26 | 0.060 |
Why?
|
| Humans | 7 | 2024 | 123258 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2010 | 2814 | 0.060 |
Why?
|
| beta-Lactams | 1 | 2023 | 50 | 0.060 |
Why?
|
| Sphingomyelins | 1 | 2023 | 16 | 0.050 |
Why?
|
| Alloys | 1 | 2023 | 16 | 0.050 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2023 | 16 | 0.050 |
Why?
|
| Electrodes | 1 | 2023 | 97 | 0.050 |
Why?
|
| Penicillins | 1 | 2023 | 154 | 0.050 |
Why?
|
| Water | 1 | 2024 | 182 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2024 | 569 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2024 | 393 | 0.050 |
Why?
|
| Hydrolysis | 1 | 2022 | 155 | 0.050 |
Why?
|
| Time Factors | 1 | 2012 | 6222 | 0.050 |
Why?
|
| Semen | 1 | 2022 | 75 | 0.050 |
Why?
|
| Testis | 1 | 2024 | 412 | 0.050 |
Why?
|
| Chromatography, Liquid | 1 | 2022 | 191 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2009 | 1523 | 0.050 |
Why?
|
| Drug Discovery | 1 | 2022 | 170 | 0.050 |
Why?
|
| Ligands | 1 | 2022 | 533 | 0.050 |
Why?
|
| Endometriosis | 1 | 2024 | 185 | 0.050 |
Why?
|
| Methacrylates | 1 | 2020 | 16 | 0.050 |
Why?
|
| Powders | 1 | 2020 | 25 | 0.050 |
Why?
|
| Filtration | 1 | 2020 | 23 | 0.050 |
Why?
|
| Surface Properties | 1 | 2020 | 76 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2022 | 228 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2023 | 782 | 0.040 |
Why?
|
| Materials Testing | 1 | 2020 | 73 | 0.040 |
Why?
|
| Nanotechnology | 1 | 2020 | 48 | 0.040 |
Why?
|
| Elasticity | 1 | 2020 | 92 | 0.040 |
Why?
|
| Cell Movement | 1 | 2024 | 831 | 0.040 |
Why?
|
| Buffers | 1 | 2020 | 31 | 0.040 |
Why?
|
| Cyclization | 1 | 2020 | 15 | 0.040 |
Why?
|
| Palladium | 1 | 2019 | 12 | 0.040 |
Why?
|
| Oxygen | 1 | 2023 | 550 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 1315 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2019 | 284 | 0.040 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2012 | 54 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2012 | 152 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 315 | 0.020 |
Why?
|
| Mutation | 1 | 2024 | 5765 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2012 | 429 | 0.020 |
Why?
|
| Male | 2 | 2024 | 60337 | 0.020 |
Why?
|